Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V.

 
DOCKET NO.
OP. BELOW
SUBJECT
Patent

Question(s) Presented

1. “Does 35 U.S.C. ยง 314(d) categorically preclude appeal of all decisions not to institute inter partes review?”

2. “Is the NHK-Fintiv Rule substantively and procedurally unlawful?”

Posts About this Case

Date
Proceedings and Orders
August 19, 2021
Motion to extend the time to file a response is granted and the time is extended to and including October 12, 2021, for all respondents.
October 1, 2021
Motion to extend the time to file a response is granted and the time is further extended to and including November 2, 2021, for all respondents.